Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data
| Príomhchruthaitheoirí: | , , , , , , , , , |
|---|---|
| Formáid: | Conference item |
| Foilsithe / Cruthaithe: |
Wiley
2018
|
| _version_ | 1826278338462744576 |
|---|---|
| author | Hawley, S Ali, M Cordtz, R Dreyer, L Edwards, C Arden, N Cooper, C Judge, A Hyrich, K Prieto-Alhambra, D |
| author_facet | Hawley, S Ali, M Cordtz, R Dreyer, L Edwards, C Arden, N Cooper, C Judge, A Hyrich, K Prieto-Alhambra, D |
| author_sort | Hawley, S |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T23:42:26Z |
| format | Conference item |
| id | oxford-uuid:6fc8c723-ad0a-4637-b1f0-2930249fb974 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:42:26Z |
| publishDate | 2018 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:6fc8c723-ad0a-4637-b1f0-2930249fb9742022-03-26T19:32:54ZComparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry dataConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:6fc8c723-ad0a-4637-b1f0-2930249fb974Symplectic Elements at OxfordWiley2018Hawley, SAli, MCordtz, RDreyer, LEdwards, CArden, NCooper, CJudge, AHyrich, KPrieto-Alhambra, D |
| spellingShingle | Hawley, S Ali, M Cordtz, R Dreyer, L Edwards, C Arden, N Cooper, C Judge, A Hyrich, K Prieto-Alhambra, D Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data |
| title | Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data |
| title_full | Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data |
| title_fullStr | Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data |
| title_full_unstemmed | Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data |
| title_short | Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data |
| title_sort | comparative effectiveness of tumour necrosis factor inhibitor therapy vs conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients a propensity score matched analysis of uk registry data |
| work_keys_str_mv | AT hawleys comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT alim comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT cordtzr comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT dreyerl comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT edwardsc comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT ardenn comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT cooperc comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT judgea comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT hyrichk comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata AT prietoalhambrad comparativeeffectivenessoftumournecrosisfactorinhibitortherapyvsconventionalsyntheticdmardsonneedforjointreplacementamongrheumatoidarthritispatientsapropensityscorematchedanalysisofukregistrydata |